Arcosa Amends Credit Agreement for New Term Loans

Arcosa ( (ACA) ) just unveiled an announcement.

On June 17, 2025, Arcosa, Inc. amended its existing credit agreement to establish a new class of term loans totaling $698,250,000. This refinancing effort allows Arcosa to prepay its previous term loan and offers a slightly reduced interest rate, enhancing its financial flexibility. The amendment includes provisions for prepayment premiums within six months if certain conditions are met, but otherwise allows prepayment without penalty.

The most recent analyst rating on (ACA) stock is a Buy with a $105.00 price target. To see the full list of analyst forecasts on Arcosa stock, see the ACA Stock Forecast page.

Spark’s Take on ACA Stock

According to Spark, TipRanks’ AI Analyst, ACA is a Outperform.

Arcosa’s overall stock score reflects strong financial performance and a positive outlook from the recent earnings call, which are tempered by a high valuation and mixed technical indicators. The company’s ability to manage profitability pressures and successful integration of acquisitions are significant strengths. However, the high P/E ratio and low dividend yield suggest valuation concerns, and technical analysis indicates a neutral trend.

To see Spark’s full report on ACA stock, click here.

More about Arcosa

Average Trading Volume: 286,014

Technical Sentiment Signal: Buy

Current Market Cap: $4.18B

See more data about ACA stock on TipRanks’ Stock Analysis page.